ROIV

#501
Roivant Sciences Ltd. Common Shares
28.9400
+3.25%
セクター:
ベース:
利益通貨:
日中レンジ
28.9400
28.9400
1年のレンジ
18.2700
29.2000
1日の変化
+3.25%
月次変化
+28.91%
6か月変化
+58.06%
1年の変化
+58.06%
以前の終値
28.0300
Open
28.9400
Bid
Ask
Low
28.9400
High
28.9400
ボリューム
275
Open full chart

Financials

Overview 明細書 Statistics Dividends
Quarterly Annual
  • Market Capitalization 19.8544 B
  • Employee 750
  • Founded 2014
  • CEO Matt Gline
  • Website www.roivant.com
  • Headquarter Bermuda
  • FIGI N/A
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-42.04
Price to sales ratio
251.93
Dividends per share
—
Dividend yield %
—

Roivant Sciences Ltd

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

ニュース